Press Releases

Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development

Read more

Bristol-Myers Squibb to Acquire IFM Therapeutics

Read more

Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration

Read more

New sPCMA White Paper: PBM Specialty Pharmacies Improve Patient Outcomes and Reduce Costs

Read more

XTL Biopharmaceuticals Appoints Mr. Alex Rabinovich to its Board of Directors

Read more

Shalini Sharp Joins Array BioPharma Board of Directors

Read more

Merck Divests Biosimilars Business to Fresenius

Read more

FDA approves first treatment for a form of Batten disease

Read more

MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations

Read more

FDA expands approved use of Stivarga to treat liver cancer

Read more